IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Illinois

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Illinois $ 13,953,940.11
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
AbaStar MDx Inc ABS-21: Schizophrenia Diagnostic Product Development $ 52,600.00 $ 191,879.25
Abiant Inc. Early, Accurate Detection and Measurement of Therapeutic Response for Dementias $ 38,826.50 $ 59,270.00
Academic Pharmaceuticals Inc Development of an Intravenous Formulation of Metolazone $ 4,500.00 $ 131,500.00
Academic Pharmaceuticals LP Aqueous Amiodarone for Treatment & Prevention of Ventricular Tachycardia & Fibrillation $ 76,848.00 $ 85,300.00
Acura Pharmaceuticals, Inc. AveRox $ 50,000.00 $ 194,479.25
Acura Pharmaceuticals, Inc. Prazatrex $ 51,650.00 $ 19,450.00
Advanced Cooling Therapy, LLC Development of an Esophageal Temperature Management Product $ 10,000.00 $ 27,500.00
Advanced Life Sciences Inc Cethromycin for Respiratory Tract Infections $ 244,479.25  
Advanced Scanning Inc. Rapid Screening Device for Young Adults to Prevent Sudden Death $ 34,188.00 $ 149,000.00
AJ Medical Devices Inc Implanted Cardiac Arrest Alarm $ 244,479.24  
Arphion LTD Oral Brush Cytology RNA Screening for Oral Cancer $ 12,038.50  
AtCor Medical Inc USA Treatment of Patients with Heart Failure through Aggressive Cardiac Load Reduction $ 109,240.00 $ 26,397.00
AuraSense, LLC Nano-Flare Platform for Intracellular Assays $ 4,455.00 $ 240,024.24
Aurora Life Sciences, LLC AutoImmune Diagnostic Array (ADA)   $ 244,479.25
B&G Partners Novel Mucin-Directed TGF-B ALK5 Inhibitors Targeted for Muc4   $ 244,479.25
B&H Biotechnologies LLC A drug candidate for prevention and treatment of serious influenza infections $ 38,940.00 $ 61,000.00
BioSante Pharmaceuticals, Inc. Phase II Development of LibiGel for Low Sexual Desire, A Significant Unmet Medical Need $ 244,479.25  
CDG Therapeutics, Inc Novel therapy for advanced refractory tumors $ 244,479.25  
Corpak Medsystems, Inc. Project Triangle - Cortrak 11 $ 244,479.25  
Endotronix Inc Reducing the Heart Failure Cost Burden:  Anytime, Anywhere Pulmonary Pressure Monitoring $ 244,479.25  
Entopy Research LLC Gastrointestinal allergy diagnostic device and method   $ 43,750.00
Errant Gene Therapeutics, LLC Thalagen, a Novel Gene Therapy for the treatment of B Thalassemia Major and Sickle Cell Anemia $ 244,479.25  
Genomics USA, Inc. Next-Generation Microarray Technology, For Low-Cost HLA-Typing $ 244,479.24  
Horizon Therapeutics, Inc HZT-501, Ibuprofen/famotidine Proprietary Combination Tablet $ 244,479.25  
Immune Cell Therapy Immune Cell Therapy's Autologous Cancer Vaccines   $ 29,955.00
Innovative Visual Systems LLC Discovery $ 128,122.50 $ 116,356.75
Jina Pharmaceuticals Inc. Development of Endoxifen: A New Cornerstone for Breast Cancer Prevention and Therapy $ 244,479.25  
Kim Laboratories, Inc Disinfectant and Diagnostic tests for Norovirus $ 170,817.50 $ 73,661.75
Lavax, Inc. Infant Formula Blocks HIV Transmission Via Breastfeeding   $95,346.50
Lenticular Research Group LLC Management of the growth of the human cystalline lens   $ 244,479.25
Lohocla Research Corporation Novel Markers for Alcohol Intake and Alcohol-Induced Organ Damage $ 141,389.57 $ 103,089.68
Metritrack LLC Automated Free Hand Breast Ultrasound Screening and Diagnosic system $ 11,861.19 $ 33,791.69
Nanoink Inc NanoEncryption $ 244,479.24  
Nanoink, Inc. NanoStemCell $ 244,479.24  
Nanosphere, Inc. Diagnostic tests for the early detection of cancer $ 244,479.25  
Nanosphere, Inc. Diagnostic tests for the detection of infectious diseases $ 244,479.25  
Nanosphere, Inc. Diagnostic tests for the early detection of immune system disorders $ 244,479.25  
Nanosphere, Inc. Diagnostic tests for the detection and prevention of cardiac and vascular diseases. $ 244,479.25  
Nanotope, Inc. Peptide-Amphiphile Nanofiber Matrix $ 244,479.25  
Naurex, Inc Improved CNS Therapies Through Development of Novel Drugs to Modulate NMDA Receptor $ 244,479.24  
NeoPharm Inc Clinical Evaluation of LEP-ETU in Cancer Patients $ 244,479.25  
NeoPharm Inc IL 13-PE as a novel, targeted therapy for Idopathic Pulmonary Fibrosis $ 244,479.25  
Nerve Access, Inc The Alzheimer Project   $ 244,479.25
NeuRDS Inc. Enabling Wireless Delivery of Electrical Stimulation Therapy $ 22,053.00 $ 105,842.00
Neuro Therpeutics Pharma Inc NTP-2014 $ 244,479.24  
NeuroTherapeutics Pharm, Inc NTP-6009 $ 9,692.50 $ 234,786.74
NovaDrug, LLC Development of novel anti-hepatitis C virus (HCV) drugs $ 244,479.25  
Novian Health Inc. Novilase Interstitial Laser Therapy $ 244,479.24  
OHMX Corporation Versatile, cost-effective point-of-care medical diagnostic device for chronic diseases $ 244,479.25  
Rhoextech. LLC Controlled coronary reperfusion during PCI for acute ischemia $ 2,379.50 $ 233,750.00
Siwa Corporation Treatment of adverse complications of diabetes through enhanced clearance of AGE-modifie   $ 65,125.00
SNAP Diagnostics SNAP Model 8 $ 104,115.50 $ 109,079.50
SteadySleepRx Company Obstructive Sleep Apnea Drug Program $ 244,479.24  
Sword Diagnostics, Inc. Improve immunoassay sensitivity & accuracy in disease ID & quantitation of biomarkers. $ 244,479.25  
Synergenz BioScience, Inc. Respiragene Lung Cancer risk Predictive test $ 20,095.00 $ 74,741.50
Tactic Pharma, LLC ATN-161   $ 244,479.24
Tactic Pharma, LLC huATN-658   $ 244,479.24
Tolerogenics Inc Use of a Bispecific Antibody for Treating Type I Diabetes $ 29,042.51 $ 51,364.31
Toltec Pharmaceuticals LLC Development of TOL-463: a vaginal biofilm disruptor for the treatment of vaginitis   $ 229,946.50
Vassol, Inc NOVA toolkit for quantitative Magnetic Resonance Angiography (qMRA) $ 242,287.50 $ 2,191.75
VesselTek BioMedical LLC Drug-eluting, elastomer-coated vascular graft $ 40,554.16 $ 40,548.16
VidaGene Identification of biomarkers for VDR activation $ 96,685.50 $ 117,064.50
Vidasym Novel VDR Modulators with Expanded Therapeutic Index and Cardio-Renal Protective Effects $ 46,779.00 $ 81,987.00
ViMedicus, LLC. ViMedicus HER 301   $ 244,479.25
Winston Laboratories, Inc Civamide Capsule $ 221,647.38 $ 22,831.86
Winston Laboratories, Inc. Civamide Nasal Spray $ 12,545.81 $ 231,933.43
Winston Laboratories, Inc. Civamide Cream $ 244,479.24  
Winston Laboratories, Inc. Civamide Patch $ 151,319.33 $ 93,159.91
zuChem inc Xylitol $ 107,207.21 $ 38,583.28
zuChem Inc Therapeutic Oligosaccharides and Glycosylated Small Molecules $ 98,427.25 $ 86,651.26
Page Last Reviewed or Updated: 04-Jun-2014